XML 86 R22.htm IDEA: XBRL DOCUMENT
v2.4.0.6

EQUITY | 12 Months Ended
--- | ---
Dec. 31, 2012
Equity [Abstract] |
Stockholders' Equity Note Disclosure [Text Block] | EQUITY
(a) | General
At the annual meeting of stockholders on June 10, 2010, the Company’s stockholders approved an amendment to its Certificate of Incorporation to increase the number of authorized shares of capital stock from 20,000,000 shares to 30,000,000 shares, all of which shall be Common Stock. The increase in authorized shares was done pursuant to a Certificate of Amendment to the Certificate of Incorporation filed with the Secretary of State of the State of Delaware on, and effective as of, June 15, 2010. At December 31, 2012 the Company had issued and outstanding 18,068,606 shares of its common stock, par value $0.01 per share. Holders of outstanding common stock are entitled to receive dividends when, as and if declared by the Board and to share ratably in the assets of the Company legally available for distribution in the event of a liquidation, dissolution or winding up of the Company. Holders of common stock do not have subscription, redemption, conversion or other preemptive rights. Holders of the common stock are entitled to elect all of the Directors on the Company’s Board. Holders of the common stock do not have cumulative voting rights, meaning that the holders of more than 50% of the common stock can elect all of the Company’s Directors. Except as otherwise required by Delaware General Corporation Law, all stockholder action is taken by vote of a majority of shares of common stock present at a meeting of stockholders at which a quorum (a majority of the issued and outstanding shares of common stock) is present in person or by proxy or by written consent pursuant to Delaware law (other than the election of Directors, who are elected by a plurality vote). The Company is not authorized to issue preferred stock. Accordingly, no preferred stock is issued or outstanding.
(b) | Dividend Reinvestment Plan
On August 15, 2012, the Company announced that it is offering its stockholders an opportunity to participate in a Dividend Reinvestment Plan ("DRIP "). The Company is offering up to 600,000 shares of its common stock for purchase under the DRIP. The DRIP provides participants the ability to invest all or a portion of cash dividends on their Acorn shares in additional shares of the Company's common stock. Initially, the Company will issue the shares under the DRIP directly at a 5% discount from the market price. The DRIP is administered by the Company's stock transfer agent. (c)Dividends In October 2011, the Board of Directors of the Company approved the payment of a quarterly dividend of $0.035 per share and a 2011 year-end special dividend of $0.05 per share which was paid in January 2012. Dividends paid since the approval of the quarterly dividend are as follows:
Period |  | Regular dividend per share |  | Special dividend per share |  | Total dividend paid per share |  | Dividend paid in cash |  | Value of dividend paid in shares under the DRIP |  | Total dividend paid |  | Value of share discount under the DRIP |  | Number of shares granted under the DRIP
Fourth quarter 2011 |  | $ | 0.035 |  |  | $ | — |  |  | $ | 0.035 |  |  | $ | 613 |  |  | $ | — |  |  | $ | 613 |  |  | $ | — |  |  | — |
Year ended December 31, 2011 |  | $ | 0.035 |  |  | $ | — |  |  | $ | 0.035 |  |  | $ | 613 |  |  | $ | — |  |  | $ | 613 |  |  | $ | — |  |  | — |
First quarter 2012 |  | $ | 0.035 |  |  | $ | 0.050 |  |  | $ | 0.085 |  |  | $ | 1,496 |  |  | $ | — |  |  | $ | 1,496 |  |  | $ | — |  |  | — |
Second quarter 2012 |  | $ | 0.035 |  |  | $ | — |  |  | $ | 0.035 |  |  | $ | 627 |  |  | $ | — |  |  | $ | 627 |  |  | $ | — |  |  | — |
Third quarter 2012 |  | $ | 0.035 |  |  | $ | — |  |  | $ | 0.035 |  |  | $ | 559 |  |  | $ | 69 |  |  | $ | 628 |  |  | $ | 4 |  |  | 8,429 |
Fourth quarter 2012 |  | $ | 0.035 |  |  | $ | — |  |  | $ | 0.035 |  |  | $ | 526 |  |  | $ | 106 |  |  | $ | 632 |  |  | $ | 6 |  |  | 14,305 |
Year ended December 31, 2012 |  | $ | 0.14 |  |  | $ | 0.05 |  |  | $ | 0.19 |  |  | $ | 3,208 |  |  | $ | 175 |  |  | $ | 3,383 |  |  | $ | 10 |  |  | 22,734 |
See Note 24 - Subsequent Events with respect to the declaration of the first quarter 2013 dividend.
(d) | Capital Raise
(i) March 2010 Capital Raise On March 8, 2010, the Company completed a registered direct offering through a placement agent of 2,231,818 shares of its common stock pursuant to separate subscription agreements between the Company and each of the investors at $5.50 per share to certain accredited investors for gross proceeds of approximately $12,275. The aggregate net proceeds from the offering, after deducting the placement agent’s fee and the offering expenses payable by the Company in connection with the offering, was $11,467. (ii) December 2010 Capital Raise On December 17, 2010, the Company entered into a Placement Agent Agreement (the “Placement Agent Agreement”) related to a registered direct offering of up to 1,150,000 shares of its common stock. Under the terms of the transaction and pursuant to separate subscription agreements between the Company and each of the investors, the Company sold the common stock at $3.50 per share for gross proceeds of $4,027. The Placement Agent Agreement provided for the payment of a placement agent fee equal to 7% ($282) of the gross proceeds of the offering, plus a warrant exercisable for an additional 80,500 shares (see Note 16(k)). The aggregate net proceeds from the offering, after deducting the placement agent’s fee and expenses in connection with the offering, was $3,709.
(e) | Summary Employee Option Information
The Company’s stock option plans provide for the grant to officers, directors and other key employees of options to purchase shares of common stock. The purchase price may be paid in cash or at the end of the option term, if the option is "in-the-money", it is automatically exercised "net" . In a net exercise of an option, the Company does not require a payment of the exercise price of the option from the optionee, but reduces the number of shares of common stock issued upon the exercise of the option by the smallest number of whole shares that has an aggregate fair market value equal to or in excess of the aggregate exercise price for the option shares covered by the option exercised. Each option is exercisable to one share of the Company’s common stock. Most options expire within five to ten years from the date of the grant, and generally vest over three year period from the date of the grant. At the annual meeting of stockholders on September 11, 2012, the Company’s stockholders approved an Amendment to the Company’s 2006 Stock Incentive Plan to increase the number of available shares by 1,000,000 and an Amendment to the Company’s 2006 Stock Incentive Plan for Non-Employee Directors to increase the number of available shares by 200,000. At December 31, 2012, 1,623,014 options were available for grant under the 2006 Amended and Restated Stock Incentive Plan and 201,667 options were available for grant under the 2006 Director Plan. In 2010 , 2011 and 2012, all options granted to non-employees were from the 2006 Amended and Restated Stock Incentive Plan which permits grants to non-employees. In connection with the stock option exercises during the years ended December 31, 2010 , 2011 and 2012, the Company received proceeds of $159, $211 and $305, respectively. The intrinsic value of options exercised in 2010 , 2011 and 2012 were $247, $707 and $1,932, respectively. The intrinsic value of options outstanding and options exercisable at December 31, 2012 was $3,585 and $3,384, respectively. Option grants to directors and officers for the years ended December 31, 2010 , 2011 and 2012 can be found below:
|  | 2010 |  | 2011 |  | 2012
|  | Number of shares |  | Weighted average exercise price |  | Number of shares |  | Weighted average exercise price |  | Number of shares |  | Weighted average exercise price
Options granted to - directors and officers (included above) during the year |  | 95,000 |  |  | $ | 4.82 |  |  | 141,666 |  |  | $ | 4.51 |  |  | 211,898 |  |  | $ | 8.02 |
Exercised by directors and officers during the year |  | 67,500 |  |  | $ | 2.36 |  |  | 159,779 |  |  | $ | 2.64 |  |  | 199,697 |  |  | $ | 3.12 |
Forfeited by directors and officers during the year |  | 120,000 |  |  | $ | 6.13 |  |  | 351,221 |  |  | $ | 3.00 |  |  | 127,803 |  |  | $ | 5.75 |
Number of options held by directors and officers at year end |  | 1,574,665 |  |  | $ | 3.69 |  |  | 1,199,999 |  |  | $ | 4.13 |  |  | 1,134,397 |  |  | $ | 4.95 |
The Company utilized the Black-Scholes option-pricing model to estimate fair value, utilizing the following assumptions for the respective years (all in weighted averages):
|  | 2010 |  | 2011 |  | 2012
Risk-free interest rate |  | 2.8 | % |  | 1.8 | % |  | 1.8 | %
Expected term of options, in years |  | 6.3 |  |  | 5.5 |  |  | 7 |
Expected annual volatility |  | 68 | % |  | 62 | % |  | 58 | %
Expected dividend yield |  | — | % |  | 1.8 | % |  | 1.3 | %
Determined weighted average grant date fair value per option |  | $ | 3.47 |  |  | $ | 2.17 |  |  | $ | 3.72 |
The expected term of the options is the length of time until the expected date of exercising the options. With respect to determining expected exercise behavior, the Company has grouped its option grants into certain groups in order to track exercise behavior and establish historical rates. The Company estimated volatility by considering historical stock volatility over the expected term of the option. The risk-free interest rates are based on the U.S. Treasury yields for a period consistent with the expected term. Up to October 17, 2011, the Company expected no dividends to be paid. On October 17, 2011, the Company approved the payment of a quarterly dividend of $0.035 per share and a 2011 year-end declaration of a special dividend of $0.050 per share (see Note 16(c)). The expected dividend yield for 2011 and 2012 takes into account the quarterly dividend per share on options grants from October 17, 2011. The Company believes that the valuation technique and the approach utilized to develop the underlying assumptions are appropriate in determining the estimated fair value of the Company’s stock options granted in the years ended December 31, 2010 , 2011 and 2012. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by persons who receive equity awards.
(f) | Non-Employee Options
On January 16, 2012, the Company granted an outside consultant an option for the purchase of 25,000 shares of the Company’s common stock. The options vest over one year, have an exercise price of $6.68 and expire after seven years. The Company used the Black-Scholes valuation method to estimate the fair value of the options granted to the consultant. The Company used a risk free interest rate of 1.4%, an expected life of seven years, an annual volatility of 60% and an annual dividend rate of 2.1% to determine the value the options granted. The Company estimated the fair value of each option granted to be $3.23. The Company recorded $115 to selling, general and administrative expense with respect to the option granted to the consultant in the year ended December 31, 2012. In addition, on December 12, 2012, the Company granted an outside consultant an option for the purchase of 5,000 shares of the Company’s common stock. The options vested immediately, have an exercise price of $7.57 and expire after seven years. The Company used the Black-Scholes valuation method to estimate the fair value of the options granted to the consultant. The Company used a risk free interest rate of 1.1%, an expected life of seven years, an annual volatility of 57% and an annual dividend rate of 1.8% to determine the value the options granted. The Company estimated the fair value of each option granted to be $3.53. The Company recorded $18 to selling, general and administrative expense with respect to the option granted to the consultant in the year ended December 31, 2012. On October 4, 2011, the Company granted an outside consultant an option for the purchase of 25,000 shares of the Company’s common stock. The options vest over 90 days, have an exercise price of $5.30 and expire after seven years. The Company used the Black-Scholes valuation method to estimate the fair value of the options granted to the consultant. The Company used a risk free interest rate of 1.3%, an expected life of seven years, an annual volatility of 62% and no expected dividends to determine the value the options granted. The Company estimated the fair value of each option granted to be $3.23. The Company recorded $79 to selling, general and administrative expense with respect to the option granted to the consultant in the year ended December 31, 2011. In January 2010, the Company granted an outside consultant an option for the purchase of 25,000 shares of the Company’s common stock. The options vested after one year, have an exercise price of $7.38 and expire after seven years. The Company used the Black-Scholes valuation method to estimate the fair value of the options granted to the consultant. The Company used a risk free interest rate of 3.4%, an expected life of seven years, an annual volatility of 69% and no expected dividends to determine the value the options granted. The Company estimated the fair value of each option granted to be $5.01. The Company recorded $124 and $1 to selling, general and administrative expense with respect to the option granted to the consultant in the year ended December 31, 2010 and 2011, respectively. In the years ended December 31, 2010 , 2011 and 2012, the Company included $139, $87 and $133 respectively, of stock-based compensation expense in selling, general and administrative expense in its Consolidated Statements of Operations with respect to options granted to non-employees.
(g) | Summary Employee and Non-Employee Option Information
A summary of the Company’s option plans as of December 31, 2010, 2011 and 2012, as well as changes during each of the years then ended, is presented below:
|  | 2010 |  | 2011 |  | 2012 |
|  | Number of Options (in shares) |  | Weighted Average Exercise Price |  | Number of Options (in shares) |  | Weighted Average Exercise Price |  | Number of Options (in shares) |  | Weighted Average Exercise Price |
Outstanding at beginning of year |  | 1,745,165 |  |  | $ | 3.52 |  |  | 1,817,665 |  |  | $ | 3.69 |  |  | 1,388,333 |  |  | $ | 4.17 |  |
Granted at market price |  | 260,000 |  |  | $ | 5.58 |  |  | 166,666 |  |  | $ | 4.63 |  |  | 348,898 |  |  | $ | 7.85 |  |
Exercised * |  | (67,500 | ) |  | $ | 2.36 |  |  | (231,831 | ) |  | $ | 2.62 |  |  | (252,453 | ) |  | $ | 3.24 |  |
Forfeited or expired |  | (120,000 | ) |  | $ | 6.13 |  |  | (364,167 | ) |  | $ | 3.00 |  |  | (173,381 | ) |  | $ | 5.10 |  |
Outstanding at end of year |  | 1,817,665 |  |  | $ | 3.69 |  |  | 1,388,333 |  |  | $ | 4.17 |  |  | 1,311,397 |  |  | $ | 5.20 |  |
Exercisable at end of year |  | 1,572,455 |  |  | $ | 3.62 |  |  | 1,267,915 |  |  | $ | 4.08 |  |  | 954,432 |  |  | $ | 4.26 |  |
* All shares issued in connection with option exercises were newly issued shares. The breakdown of option exercises between cashless net exercises and cash exercises is as follows the years ended December 31, 2010 , 2011 and 2012:
|  | Shares granted in net exercise of options |  | Options forfeited in net exercise of options |  | Total net exercise options |  | Weighted average exercise price for net exercise options |  | Options exercised for cash |  | Weighted average exercise price for options exercised for cash
Year ended December 31, 2010 |  | — |  |  | — |  |  | — |  |  | $— |  | — |  |  | $—
Year ended December 31, 2011 |  | 148,165 |  |  | 304,167 |  |  | 452,332 |  |  | $2.69 |  | 83,666 |  |  | $2.51
Year ended December 31, 2012 |  | 101,619 |  |  | 148,381 |  |  | 250,000 |  |  | $5.06 |  | 150,834 |  |  | $2.02
Summary information regarding the options outstanding and exercisable at December 31, 2012 is as follows:
|  | Outstanding |  | Exercisable
Range of Exercise Prices |  | Number Outstanding |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price |  | Number Exercisable |  | Weighted Average Exercise Price
|  | (in shares) |  | (in years) |  |  |  | (in shares) |  |
$2.24 – $2.56 |  | 157,500 |  |  | 1.68 |  | $2.44 |  | 156,875 |  |  | $2.44
$3.28 – $3.90 |  | 229,166 |  |  | 1.65 |  | $3.51 |  | 229,166 |  |  | $3.51
$4.09 – $4.96 |  | 188,333 |  |  | 3.52 |  | $4.48 |  | 171,666 |  |  | $4.43
$5.05 – $5.50 |  | 362,500 |  |  | 5.05 |  | $5.15 |  | 362,500 |  |  | $5.15
$6.49 - $7.57 |  | 257,000 |  |  | 6.94 |  | $7.19 |  | 30,000 |  |  | $7.41
$7.38 - $11.42 |  | 116,898 |  |  | 6.66 |  | $9.21 |  | 4,225 |  |  | $7.60
|  | 1,311,397 |  |  |  |  |  |  | 954,432 |  |  |
Stock-based compensation expense included in the Company’s Statements of Operations was:
|  | Year ended December 31,
|  | 2010 |  | 2011 |  | 2012
Research and development expense |  | $ | — |  |  | $ | — |  |  | $ | 81 |
Selling, general and administrative expense* |  | 690 |  |  | 458 |  |  | 774 |
Total stock compensation expense |  | $ | 690 |  |  | $ | 458 |  |  | $ | 855 |
* Stock compensation expense in 2011 includes $51 with respect to stock granted to consultants. In addition to the above amounts, the Company recorded stock compensation expense of $339 which is included in Loss from discontinued operations, net of income taxes with respect to Coreworx with respect to the period ended December 17, 2010, respectively. The Company also recorded stock compensation expense of $440 and $176 with respect to CoaLogix operations in the year ended December 31, 2010, and the period ended August 31, 2011, respectively which are also included in the Loss from discontinued operations, net of income taxes. As at December 31, 2012, the total compensation cost related to non-vested awards not yet recognized was approximately $937 which the Company expects to recognize over a weighted-average period of approximately 1.8 years.
(h) | DSIT Stock Option Plan
In November 2006, the Company adopted a Key Employee Stock Option Plan (the “DSIT Plan”) for its DSIT subsidiary to be administrated by a committee of board members of DSIT, currently comprised of the entire board of directors of DSIT. The purpose of the DSIT Plan and associated grants is to provide incentives to key employees of DSIT to further the growth, development and financial success of DSIT. A summary status of the DSIT Plan as of December 31, 2010, 2011 and 2012, as well as changes during the years then ended, is presented below:
|  | 2010 |  | 2011 |  | 2012
|  | Number of Options (in shares) |  | Weighted Average Exercise Price |  | Number of Options (in shares) |  | Weighted Average Exercise Price |  | Number of Options (in shares) |  | Weighted Average Exercise Price
Outstanding at beginning of year |  | 152,400 |  |  | $ | 1.18 |  |  | 152,400 |  |  | $ | 1.18 |  |  | 240,824 |  |  | $ | 1.67 |
Granted at fair value |  | — |  |  | — |  |  | 93,054 |  |  | 2.45 |  |  | — |  |  | $ | — |
Exercised |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Forfeited |  | — |  |  | — |  |  | (4,630 | ) |  | 1.09 |  |  | (2,060 | ) |  | $ | 2.51 |
Outstanding at end of year |  | 152,400 |  |  | $ | 1.18 |  |  | 240,824 |  |  | $ | 1.67 |  |  | 238,764 |  |  | 1.69 |
Exercisable at end of year* |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
* Options vest only upon an exit event for the Company. On August 10, 2011, DSIT granted options to purchase 93,054 of its ordinary shares to senior management and employees of DSIT at an exercise price of NIS 9.38 per share and exercisable for a period of seven years. These options vest and become exercisable only upon the occurrence of an initial public offering of DSIT or a merger, acquisition, reorganization, consolidation or similar transaction involving DSIT. In addition, DSIT also extended the expiration date of 147,770 previously granted options from December 31, 2013 to August 10, 2018. No other option terms were modified. Summary information regarding the options under the Plan outstanding and exercisable at December 31, 2012 is as follows:
|  | Outstanding |  | Exercisable
Range of Exercise Prices |  | Number Outstanding |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price |  | Number Exercisable |  | Weighted Average Exercise Price
|  | (in shares) |  | (in years) |  |  |  | (in shares) |  |
$1.05 – $1.26 |  | 147,770 |  |  | 6.6 |  | $ | 1.18 |  |  | — |  |  | — |
$2.51 |  | 90,994 |  |  | 6.6 |  | $ | 2.51 |  |  | — |  |  | — |
|  | 238,764 |  |  |  |  | $ | 1.69 |  |  | — |  |  | — |
If all the options in the DSIT Plan are exercised, the Company’s holdings in DSIT will be diluted from 84% to approximately 71.4% (see Note 24 - Subsequent Events).
(i) | DSIT Warrants
In August 2012, the warrant to purchase 10% of DSIT issued in August 2005 to the purchaser of the Company's former dsIT Technologies, Ltd. subsidiary expired.
(j) | USSI Stock Option Plan
In connection with the USSI Purchase Agreement, the Company established a new 2012 Stock Plan (the “USSI 2012 Stock Option Plan” or the "Plan") under which key employees, directors and consultants of USSI may receive options to purchase up to an aggregate of 1,180,000 shares of USSI Common Stock on such terms as the Plan provides and as determined by USSI's board of directors or by such committee designated by USSI's board to administer the Plan, if any. In September 2012, USSI granted options to purchase 637,375 of its common shares, to senior management, employees, outside directors and a consultant of USSI under the Plan. The options were granted with an exercise price of $1.72 per share based on a valuation performed by an independent third party and are exercisable for a period of seven years. The options vest over a three to four year period based on date of hire or other benchmark specified in the option agreement. Upon exercise of all the options in the Plan, the Company’s holdings in USSI will be diluted from 94.4% to approximately 85.1% (see Note 3(c)). During the year ended December 31, 2012, $323 was recorded as stock compensation expense with respect to the abovementioned options ($80 in Research and development expenses, net of credits and $243 in Selling, general and administrative expenses). The purposes of the Plan for our USSI subsidiary are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to service providers and to promote the success of the business of USSI. A summary status of the USSI 2012 Stock Option Plan as of December 31, 2012, as well as changes during the year then ended, is presented below :
|  | 2012
|  | Number of Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life
|  | (in shares) |  |  |  | (in years)
Outstanding at beginning of year |  | — |  |  | $ | — |  |  |
Granted at fair value |  | 637,375 |  |  | $ | 1.72 |  |  |
Exercised |  | — |  |  | $ | — |  |  |
Forfeited |  | (5,000 | ) |  | $ | 1.72 |  |  |
Outstanding at end of year |  | 632,375 |  |  | $ | 1.72 |  |  | 6.7
Exercisable at end of year |  | 322,337 |  |  | $ | 1.72 |  |  | 6.7
(k) | Warrants
The Company has issued warrants at exercise prices equal to or greater than market value of the Company’s common stock at the date of issuance. A summary of warrant activity follows:
|  | 2010 |  | 2011 |  | 2012
|  | Number of shares underlying warrants |  | Weighted Average Exercise Price |  | Number of shares underlying warrants |  | Weighted Average Exercise Price |  | Number of shares underlying warrants |  | Weighted Average Exercise Price
Outstanding at beginning of year |  | 246,904 |  |  | $ | 4.50 |  |  | 313,806 |  |  | $ | 4.29 |  |  | 313,806 |  |  | $ | 4.29 |
Granted |  | 80,500 |  |  | 3.68 |  |  | — |  |  | $ | — |  |  | — |  |  | — |
Exercised |  | (13,598 | ) |  | $ | 4.50 |  |  | — |  |  | $ | — |  |  | (269,808 | ) |  | 4.35 |
Forfeited or expired |  | — |  |  | — |  |  | — |  |  | — |  |  | (15,248 | ) |  | 3.68 |
Outstanding and exercisable at end of year |  | 313,806 |  |  | $ | 4.29 |  |  | 313,806 |  |  | $ | 4.29 |  |  | 28,750 |  |  | $ | 3.68 |
The warrants outstanding at December 31, 2012 expire on December 17, 2015. The 80,500 warrants that were granted in connection with the December 2010 Capital Raise (see Note 16(d)(ii)) are exercisable for shares of the Company’s Common Stock for five years at an exercise price of $3.68 per share. The Company allocated $153 to the value of the warrants based on a Black Scholes calculation using a five year expected life, an annual volatility of 59%, a discount rate of 2.0% and no dividends. The value allocated to the warrants was offset against additional paid-in-capital. During the year ended December 31, 2010 and 2012, the Company received proceeds of $61 and $1,050, respectively, from the exercise of warrants. No warrants were exercised in 2011. During the year ended December 31, 2012, 36,502 warrants were exercised and 15,248 warrants were forfeited in connection with the cashless net exercise of 51,750 warrants at a weighted average exercise price of $3.68 per share.
(l) | Treasury shares
The Company used 473,161 of its treasury shares to acquire shares of USSI (see Note 3(c)). The treasury shares had a basis of $1,791 and a value of $2,229 on the date of the transfer. In accordance with generally accepted accounting principles, the Company recorded an adjustment of $438 to additional paid-in-capital as a result of the transfer of the treasury shares. As at December 31, 2011 and 2012, the Company owned a total of 801,920 of its own shares.

X
- Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Preferred Stock -URI http://asc.fasb.org/extlink&oid=6521494 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Section B -Paragraph 7, 11A -Chapter 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section C Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph d -Article 4 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 17: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707 Reference 18: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 19: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 20: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 21: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 22: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(d),(e)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 23: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Article 4 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration